Search

Search Results

• 

  Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

  Carlos A. Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther Rodríguez Gonzalez, Concepción Rodriguez Garcia, Oriol Armengol, Emilia Abad, Teresa Peña, Adolfo Domenech del Rio, Juan A. Riesco Miranda

  2017-12-19

  https://doi.org/10.4081/monaldi.2017.874

  2186

  PDF: 1102

  Supplementary: 311
• 

  Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD

  Claudio F. Donner, Sandro Amaducci, Elena Bacci, Sandra Baldacci, Maria L. Bartoli, Gianfranco M. Beghi, Alida Benfante, Sara Brighindi, Lucio Casali, Daniela Castiglia, Mario Cazzola, Alessandro Celi, Silvana Cianchetti, Giorgio Colombo, Claudia Crimi, Federico L. Dente, Giuseppe Di Maria, Annalisa Di Maria, Manuela Latorre, Federico Lavorini, Sara Maio, Claudia Mannini, Riccardo Messina, Pier Luigi Paggiaro, Patrizia Pignatti, David Price, Nicola Scichilone, Marzia Simoni, Antonio Spanevello, Martina Stagno d’Alcontres, Shawna Tan, Roberto Torchio, Giovanni Viegi, Dina Visca, Emiel F.M. Wouters, Shaylynn Yu Hui Xin

  2018-02-02

  https://doi.org/10.4081/monaldi.2018.886

  3859

  PDF: 1873

• Features of hospitalisations for acute exacerbation of COPD resulting in death

  T. Kinnunen, O. Säynäjäkangas, T. Keistinen

  2016-02-03

  https://doi.org/10.4081/monaldi.2007.504

  1200

  PDF: 628

• Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence

  P. Trerotoli, N. Bartolomeo, A.M. Moretti

  2016-01-26

  https://doi.org/10.4081/monaldi.2008.386

  1081

  PDF: 584

• Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study

  Alberto Papi, Maria Sandra Magnoni, Carmelo Caio Muzzio, Gianmarco Benso, Andrea Rizzi

  2016-10-14

  https://doi.org/10.4081/monaldi.2016.721

  3322

  PDF: 1903

• The use of roflumilast in COPD: a review

  Andrea Zanini, Francesca Cherubino, Patrizia Pignatti

  2015-08-19

  https://doi.org/10.4081/monaldi.2013.27

  1445

  PDF: 769

• Smoking cessation treatment for COPD smokers: the role of counselling

  C.A. Jiménez-Ruiz, K.O. Fagerström

  2015-11-26

  https://doi.org/10.4081/monaldi.2013.107

  3233

  PDF: 1567

• Smoking cessation treatment for COPD smokers: the role of pharmacological interventions

  C.A. Jiménez-Ruiz, K.O. Fagerström

  2015-11-26

  https://doi.org/10.4081/monaldi.2013.106

  3459

  PDF: 1963

• Different outcomes of pulmonary rehabilitation in patients with COPD with or without exacerbations

  G.G. Riario-Sforza, C. Incorvaia, F. Paterniti, N. Dugnani, M. Fumagalli

  2005-09-30

  https://doi.org/10.4081/monaldi.2005.629

  1431

  PDF: 682

• Blood and sputum eosinophilia in chronic obstructive pulmonary disease patients and their association with exacerbations: a prospective observational study from a tertiary care center

  Dhiresh Jaiswal, Man Mohan Puri, Shalini Mullick, Vikas Kumar

  2026-04-08

  https://doi.org/10.4081/monaldi.2026.3619

  380

  PDF_EARLY VIEW: 247

• Potential benefits of integrated COPD management in primary care

  A.L. Kruis, N.H. Chavannes

  2016-01-19

  https://doi.org/10.4081/monaldi.2010.297

  3719

  PDF: 1561

• Roflumilast is effective in reducing COPD related exacerbations and improving CAT score

  Biagio Polla

  2015-08-19

  https://doi.org/10.4081/monaldi.2013.32

  1196

  PDF: 734

• Rehabilitation of COPD patients: which training modality

  E. Clini, S. Costi, M. Romagnoli, F. Florini

  2004-09-30

  https://doi.org/10.4081/monaldi.2004.697

  1641

  PDF: 774

• Randomized trial of paroxetine in end-stage COPD

  Y. Lacasse, L. Beaudoin, L. Rousseau, F. Maltais

  2004-09-30

  https://doi.org/10.4081/monaldi.2004.692

  2785

  PDF: 926

• Relationship of fractional exhaled nitric oxide with blood eosinophilia in characterizing type-2 airway inflammation in treatment-naïve patients with chronic obstructive pulmonary disease

  Riksoam Chatterjee, Mansi Gupta, Zia Hashim, Ajmal Khan, Alok Nath, Vikas Aggarwal

  2025-07-21

  https://doi.org/10.4081/monaldi.2025.3315

  1102

  PDF_EARLY VIEW: 2398
• 

  Identification of subclinical cognitive impairment in chronic obstructive pulmonary disease using auditory P300 event related potential

  Soundariya Krishnamurthy, Yuvarajan Sivagnaname, Gokul Chandu Gumallapu

  2019-05-24

  https://doi.org/10.4081/monaldi.2019.1039

  1902

  PDF: 1121

• Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea. Association, consequences and treatment

  C. Pronzato

  2016-01-19

  https://doi.org/10.4081/monaldi.2010.285

  2597

  PDF: 1654
• 

  Role of interleukin-6 and insulin resistance as screening markers for metabolic syndrome in patients of chronic obstructive pulmonary disease. A hospital-based cross-sectional study

  Manu Dogra, Surabhi Jaggi, Deepak Aggarwal, Seema Gupta, Varinder Saini, Jasbinder Kaur

  2021-12-28

  https://doi.org/10.4081/monaldi.2021.2024

  3353

  PDF: 909

• Exacerbations and associated healthcare cost in patients with COPD in general practice

  T.R.J. Schermer, C.G.J. Saris, W.J.H.M. Van den Bosch, N.H. Chavannes, C.P. Van Schayck, P.N.R. Dekhuijzen, C. Van Weel

  2016-02-11

  https://doi.org/10.4081/monaldi.2006.558

  1435

  PDF: 715

• Two cases of COPD benefitting from therapy with roflumilast

  Chiara Francesca Carraro

  2015-08-19

  https://doi.org/10.4081/monaldi.2013.29

  1224

  PDF: 821

• Impact of the COVID-19 pandemic on the clinical features of patients with chronic obstructive pulmonary disease: an observational cross-sectional study

  Gaukhar Kurmanova, Almas Zhanaev, Akzharkyn Kaldybek, Balkiya Abdrakhmanova, Almira Akparova

  2024-11-20

  https://doi.org/10.4081/monaldi.2024.3128

  1918

  PDF: 101

  SUPPLEMENTARY MATERIAL: 131

• Significant gas-exchange improvements reported after roflumilast in two cases of severe COPD

  Bruno Sposato

  2015-08-19

  https://doi.org/10.4081/monaldi.2013.33

  984

  PDF: 763

• Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study

  Ombretta Para, Marco Vanetti, Chiara Dibonaventura, Davide Salerno, Lorenzo Caruso, Christian Carleo, Asim Raza, Carlo Nozzoli, Antonio Spanevello

  2025-02-04

  https://doi.org/10.4081/monaldi.2025.3157

  1739

  PDF: 83

• Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect?

  Srishankar Bairy, Tarun Tiwari, Himanshu Mittal, Neeraj Gupta, Meghana M

  2025-01-22

  https://doi.org/10.4081/monaldi.2025.3129

  2084

  PDF: 186
• 

  There’s no place like home: Integrating pulmonary rehabilitation into the home setting

  Madalina Macrea, Richard ZuWallack, Linda Nici

  2017-07-18

  https://doi.org/10.4081/monaldi.2017.859

  3270

  PDF: 1533

• Real-world data on home high-flow nasal cannula oxygen therapy in end-stage respiratory disease

  Pedro Magalhães Ferreira, Mariana Ribeiro, Miguel Gonçalves, Carla Damas

  2025-02-24

  https://doi.org/10.4081/monaldi.2025.3269

  1462

  PDF_EARLY VIEW: 472

• GP management of community-acquired pneumonia in Italy: the ISOCAP study

  C.M. Sanguinetti, F. De Benedetto, C.F. Donner

  2005-03-30

  https://doi.org/10.4081/monaldi.2005.654

  1104

  PDF: 684

• Current management of spontaneous pneumothorax

  P.E. Van Schil, J.M. Hendriks, M.G. De Maeseneer, P.R. Lauwers

  2005-12-30

  https://doi.org/10.4081/monaldi.2005.622

  1617

  PDF: 724

• Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment

  Bruno Balbi

  2015-08-19

  https://doi.org/10.4081/monaldi.2013.26

  1333

  PDF: 737

• Role of detailed psychological evaluation and treatment in pulmonary rehabilitation programs for patients with chronic obstructive pulmonary disease

  Anna Jacob, Kranti Garg, Kashish Dutta, Varinder Saini, Deepak Aggarwal, Ajeet Sidana

  2024-02-27

  https://doi.org/10.4081/monaldi.2024.2849

  2542

  PDF: 605

• Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine

  Federico Baraldi, Tommaso Bigoni, Maria Pia Foschino Barbaro, Claudio Micheletto, Giulia Scioscia, Alessandro Vatrella, Alberto Papi

  2025-01-14

  https://doi.org/10.4081/monaldi.2025.3159

  3578

  PDF: 231

• Clinical use of Heliox in Asthma and COPD

  G. Valli, P. Paoletti, D. Savi, D. Martolini, P. Palange

  2016-02-03

  https://doi.org/10.4081/monaldi.2007.488

  2329

  PDF: 837

• Roflumilast succeeds where traditional therapy fails: a case report

  Gabriella Guarnieri

  2015-08-19

  https://doi.org/10.4081/monaldi.2013.30

  1097

  PDF: 740

• Prevalence and predictors of suboptimal peak inspiratory flow rates in the management of chronic obstructive pulmonary disease

  Madhusmita Mohanty Mohapatra, Mahesh Babu Vemuri, Vinod Kumar Saka, Pratap Upadhya, Vishnukanth Govindharaj

  2024-12-24

  https://doi.org/10.4081/monaldi.2024.3210

  1357

  PDF: 196

• Serum lactate dehydrogenase and its isoenzymes as predictors of clinical outcomes in acute exacerbation of chronic obstructive pulmonary disease: a retrospective analysis of a hospitalized cohort

  Dimitrios Papadopoulos, Vlasios Skopas, Nikolaos Trakas, Eleni Papaefstathiou, Nikolaos Tzogas, Demosthenes Makris, Zoe Daniil, Konstantinos Gourgoulianis

  2023-06-07

  https://doi.org/10.4081/monaldi.2023.2543

  2072

  PDF: 813
• 

  Use of inhaled devices during a hospital exacerbation of COPD: a summary of an interdisciplinary audit held at ICS Maugeri Pavia, Italy (March-June 2019)

  Michele Vitacca, Cinzia Lastoria, Monica Delmastro, Domenico Fiorenza, Pasquale De Cata, Barbara Fusar Poli, Sonia Gilè, Paola Prometti, Mara Paneroni, Cristina Bianchi, Elena Mandora, Roberta Porri, Claudio Fracchia

  2020-02-12

  https://doi.org/10.4081/monaldi.2020.1176

  2536

  PDF: 1583

  Supplementary: 354
• 

  Clinical course of COPD in patients with Arg16Gly (rs1042713) polymorphism of ADRB2 gene

  Kostiantyn Dmytriiev, Yuriy Mostovoy, Nataliia Slepchenko, Yuliia Smereka

  2022-09-13

  https://doi.org/10.4081/monaldi.2022.2314

  1657

  PDF: 528

• Assessment of left ventricular function in subjects with chronic obstructive pulmonary disease

  Murali Mupparapu, Rajesh Venkataram, Nandakishore Baikunje, Ivor D’Sa, Chandramouli Mandya Thimmaiah

  2023-10-16

  https://doi.org/10.4081/monaldi.2023.2654

  1311

  PDF: 382

• Hormonal harmony disrupted: hypothyroidism and diabetes mellitus in interstitial lung disease. An observational study

  Manju Bala, Akhlesh Rajpoot, Dinesh Chandra Punera, Suyash Singh Rathore

  2024-07-23

  https://doi.org/10.4081/monaldi.2024.2956

  5785

  PDF: 562
• 

  Tiotropium: a new therapeutic option in asthma

  F. Novelli, F. Costa, M. Latorre, L. Malagrinò, A. Celi, B. Vagaggini, P. Paggiaro

  2013-12-30

  https://doi.org/10.4081/monaldi.2013.9

  2628

  PDF: 1348

• Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study

  G. Caramori, M. Fabbri, D. Paioli, F. Falcone, C. Severino, G. Felisatti, O. Arar, I.M. Adcock, K. Fan Chung, P.J. Barnes, A. Ciaccia, A. Papi

  2005-06-30

  https://doi.org/10.4081/monaldi.2005.643

  1487

  PDF: 634
• 

  Review of the association between periodontitis and chronic obstructive pulmonary disease in smokers

  Agathi Spiropoulou, Nicholas Zareifopoulos, Aggeliki Bellou, Konstantinos Spiropoulos, Lazaros Tsalikis

  2019-03-20

  https://doi.org/10.4081/monaldi.2019.1018

  4478

  PDF: 2759

• Ocular manifestations of common pulmonary diseases: a narrative review

  Mamta Singh, Kunal Deokar, Bibhuti Prassan Sinha, Monika Keena, Govind Desai

  2023-03-03

  https://doi.org/10.4081/monaldi.2023.2535

  5015

  PDF: 1996

• The patients with severe Chronic Obstructive Pulmonary Disease and chronic respiratory insufficiency

  N. Ambrosino, M. Di Giorgio, A. Di Paco

  2016-02-03

  https://doi.org/10.4081/monaldi.2007.486

  1301

  PDF: 807

• Downhill: a new rehabilitation frontier. A systematic review of the literature

  Matteo Tamburlani, Rossana Cuscito, Alessio D’Angelo, Giovanni Galeoto, Leonardo Papi, Ilaria Ruotolo, Francesca Santini, Annamaria Servadio, Edoardo Tirelli, Giovanni Sellitto

  2025-01-16

  https://doi.org/10.4081/monaldi.2025.3071

  1645

  PDF: 309

  SUPPLEMENTARY MATERIAL: 83

• Delayed functional improvement after near-fatal bleeding complication following endobronchial valve therapy for emphysema

  Sergio Baldi, Francesco Coni, Giorgio Limerutti, Massimo Baccega, Enrico Ruffini, Paolo Solidoro

  2016-06-22

  https://doi.org/10.4081/monaldi.2015.748

  1897

  PDF: 830

• Telemedicine: a new frontier for effective healthcare services

  S. Scalvini, M. Vitacca, L. Paletta, A. Giordano, B. Balbi

  2004-12-30

  https://doi.org/10.4081/monaldi.2004.686

  4322

  PDF: 1984

• Classification of chronic obstructive pulmonary disease as ABCD according to the GOLD 2011 and 2017 versions in patients at the University Medical Center in Ho Chi Minh City, Vietnam

  Vinh Nguyen-Nhu, Lam-Phuoc Nguyen, Sy Duong-Quy, Pham Le An, Tri Bui-Minh

  2023-07-28

  https://doi.org/10.4081/monaldi.2023.2619

  2596

  PDF: 599

  SUPPLEMENTARY MATERIAL: 96
• 

  Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series

  Brandon Iturbe Esquivel, José Meneses Calderón, Luis Edgar Concepción Carrillo, Hugo Mendieta Zeron

  2022-06-08

  https://doi.org/10.4081/monaldi.2022.2143

  2951

  PDF: 921
• 

  Hospital treatment of severe acute exacerbation of chronic obstructive pulmonary disease in COVID-19 situation: back to basics

  Pratap Upadhya, Rohit Vadala, Arpitha A

  2020-09-22

  https://doi.org/10.4081/monaldi.2020.1424

  2194

  PDF: 1336